Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands

AIM: The aim of this study was to perform a cost-effectiveness analysis to establish the cost-effectiveness of sensor-augmented pump therapy (SAP) with automated insulin suspension vs continuous subcutaneous insulin infusion (CSII) alone in patients with type 1 diabetes in the Netherlands. PATIENTS...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clinicoecon Outcomes Res
Hlavní autoři: Roze, Stephané, Smith-Palmer, Jayne, de Portu, Simona, Delbaere, Alexis, de Brouwer, Bonnie, de Valk, Harold W
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2019
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6336135/
https://ncbi.nlm.nih.gov/pubmed/30679914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S186298
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky